tiprankstipranks
Trending News
More News >
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Ratios

Compare
743 Followers

Caribou Biosciences Ratios

CRBU's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, CRBU's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
11.97 11.97 9.25 15.15 1.96
Quick Ratio
11.97 11.97 11.48 16.35 1.77
Cash Ratio
1.81 1.81 2.07 9.31 1.29
Solvency Ratio
-1.54 -1.54 -1.31 -1.21 -0.56
Operating Cash Flow Ratio
-3.30 -3.30 -3.23 -1.26 -2.68
Short-Term Operating Cash Flow Coverage
0.00 0.00 -94.17 0.00 -50.79
Net Current Asset Value
$ 275.03M$ 275.03M$ 187.35M$ 336.66M$ -35.18M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.06 0.07 <0.01 0.04
Debt-to-Equity Ratio
0.07 0.07 0.09 <0.01 -0.07
Debt-to-Capital Ratio
0.07 0.07 0.08 <0.01 -0.07
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 -0.04
Financial Leverage Ratio
1.17 1.17 1.24 1.14 -1.54
Debt Service Coverage Ratio
0.00 0.00 -108.54 -8.29K -49.54
Interest Coverage Ratio
0.00 0.00 0.00 -8.37K -1.81K
Debt to Market Cap
0.00 0.00 <0.01 0.00 <0.01
Interest Debt Per Share
0.37 0.37 0.46 <0.01 0.03
Net Debt to EBITDA
0.21 0.21 0.29 3.64 0.41
Profitability Margins
Gross Profit Margin
-225.07%-225.07%73.71%89.75%-178.50%
EBIT Margin
-336.63%-336.63%-768.17%-697.84%-292.10%
EBITDA Margin
-326.40%-326.40%-756.46%-687.59%-284.82%
Operating Profit Margin
-336.63%-336.63%-768.17%-697.84%-292.24%
Pretax Profit Margin
-295.49%-295.49%-717.28%-693.92%-292.27%
Net Profit Margin
-296.05%-296.05%-717.79%-697.26%-277.55%
Continuous Operations Profit Margin
-296.05%-296.05%-717.79%-697.26%-277.55%
Net Income Per EBT
100.19%100.19%100.07%100.48%94.96%
EBT Per EBIT
87.78%87.78%93.38%99.44%100.01%
Return on Assets (ROA)
-23.62%-23.62%-26.60%-15.13%-95.18%
Return on Equity (ROE)
-27.71%-27.71%-33.04%-17.26%146.38%
Return on Capital Employed (ROCE)
-28.73%-28.73%-30.78%-16.08%-152.70%
Return on Invested Capital (ROIC)
-28.70%-28.70%-30.63%-16.16%-141.11%
Return on Tangible Assets
-23.62%-23.62%-25.87%-15.03%-89.04%
Earnings Yield
-24.13%-24.13%-26.04%-7.36%-3.51%
Efficiency Ratios
Receivables Turnover
8.93 8.93 2.97 1.18 2.40
Payables Turnover
35.92 35.92 3.18 0.25 13.24
Inventory Turnover
0.00 0.00 -0.06 -0.03 14.15
Fixed Asset Turnover
0.85 0.85 0.40 1.96 3.53
Asset Turnover
0.08 0.08 0.04 0.02 0.34
Working Capital Turnover Ratio
0.13 0.13 0.05 0.05 0.42
Cash Conversion Cycle
30.69 30.69 -6.26K -12.71K 150.59
Days of Sales Outstanding
40.85 40.85 122.91 308.95 152.37
Days of Inventory Outstanding
0.00 0.00 -6.27K -11.54K 25.80
Days of Payables Outstanding
10.16 10.16 114.88 1.48K 27.58
Operating Cycle
40.85 40.85 -6.15K -11.23K 178.16
Cash Flow Ratios
Operating Cash Flow Per Share
-1.26 -1.26 -1.50 -0.54 -0.55
Free Cash Flow Per Share
-1.42 -1.42 -1.61 -0.59 -0.58
CapEx Per Share
0.16 0.16 0.12 0.05 0.02
Free Cash Flow to Operating Cash Flow
1.12 1.12 1.08 1.10 1.04
Dividend Paid and CapEx Coverage Ratio
-8.03 -8.03 -12.90 -10.42 -25.26
Capital Expenditure Coverage Ratio
-8.03 -8.03 -12.90 -10.42 -25.26
Operating Cash Flow Coverage Ratio
-3.44 -3.44 -3.28 -125.56 -21.05
Operating Cash Flow to Sales Ratio
-2.71 -2.71 -6.57 -3.39 -2.69
Free Cash Flow Yield
-24.80%-24.80%-25.67%-3.92%-3.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.14 -4.14 -3.84 -13.59 -28.53
Price-to-Sales (P/S) Ratio
12.27 12.27 27.57 94.75 79.18
Price-to-Book (P/B) Ratio
1.15 1.15 1.27 2.34 -41.76
Price-to-Free Cash Flow (P/FCF) Ratio
-4.03 -4.03 -3.90 -25.52 -28.34
Price-to-Operating Cash Flow Ratio
-4.53 -4.53 -4.20 -27.96 -29.47
Price-to-Earnings Growth (PEG) Ratio
0.26 0.26 -0.08 -0.14 -0.62
Price-to-Fair Value
1.15 1.15 1.27 2.34 -41.76
Enterprise Value Multiple
-3.54 -3.54 -3.35 -10.14 -27.39
Enterprise Value
398.86M 398.86M 351.24M 669.21M 964.35M
EV to EBITDA
-3.54 -3.54 -3.35 -10.14 -27.39
EV to Sales
11.57 11.57 25.36 69.72 78.02
EV to Free Cash Flow
-3.80 -3.80 -3.58 -18.78 -27.93
EV to Operating Cash Flow
-4.28 -4.28 -3.86 -20.58 -29.03
Tangible Book Value Per Share
4.99 4.99 4.95 6.44 -0.39
Shareholders’ Equity Per Share
4.99 4.99 4.95 6.44 -0.39
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 0.05
Revenue Per Share
0.47 0.47 0.23 0.16 0.21
Net Income Per Share
-1.38 -1.38 -1.64 -1.11 -0.57
Tax Burden
1.00 1.00 1.00 1.00 0.95
Interest Burden
0.88 0.88 0.93 0.99 1.00
Research & Development to Revenue
3.25 3.25 5.94 5.44 2.78
SG&A to Revenue
1.12 1.12 2.74 2.53 1.14
Stock-Based Compensation to Revenue
0.40 0.40 0.85 0.36 0.08
Income Quality
0.91 0.91 0.91 0.49 0.97
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis